STAT

A fertility app bills itself as contraception, raising questions about marketing and efficacy

A fertility tracking app, Dot, is billing itself as contraception — and touting the results of a new efficacy study. But there’s also significant debate over how to measure the…
Source: Indranil Mukherjee/AFP/Getty Images

A new fertility tracking app, Dot, is billing itself as form of contraception — and touting the results of a new efficacy study that shows the app may be up to 99 percent effective as a form of birth control.

With statistics like that, Dot — part of a surge in fertility and contraception apps — would appear to be one of the most effective birth control tools available.

But there’s also significant debate over how to measure the effectiveness of these tools, as well as questions about which apps should be available in the first place. Although Dot is being touted as a form of contraception, it has not yet undergone a Food and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks